🔎 Trials Near Me

Početna › Debljina › Florida › Miami

Kliničke studije za Debljina u gradu Miami, FL

27 studija za Debljina traži sudionike na lokacijama u gradu Miami i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

U tijeku regrutacijaFaza 1
  • Clinical Pharmacology of Miami, Miami
Od 18 do 65 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT07399678

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

U tijeku regrutacijaFaza 3
  • PharmaDev Clinical Research Institute LLC, Miami
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07668414

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

U tijeku regrutacijaFaza 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937086

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

U tijeku regrutacijaFaza 1
  • Clinical Pharmacology of Miami, Miami
Od 18 do 70 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT07803744

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
  • New Horizon Research Center, Miami
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

U tijeku regrutacijaFaza 3
  • New Horizon Research Center, Miami
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Flourish Research - Miami, LLC, Miami
  • PharmaDev Clinical Research Institute, LLC, Miami
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

U tijeku regrutacijaFaza 3
  • Finlay Medical Research, Miami
  • Suncoast Research Group LLC, Miami
  • New Horizon Research Center, Miami
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • BioMed Research & Medical Center, Miami
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • New Horizon Research Center, Miami
Od 18 do 75 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07589608

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

U tijeku regrutacijaFaza 3
  • PharmaDev Clinical Research Institute LLC, Miami
Od 18 godina i više · Oba spola · Ažurirano 11. ruj 2026. · NCT07571005

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
  • ACCOMPLISH-2 Research Site, Miami
Od 18 do 79 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • New Horizon Research Center, Miami
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

U tijeku regrutacijaFaza 3
  • Kailera Clinical Site, Miami
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

U tijeku regrutacijaFaza 3
  • Optimus U Corporation, Miami
  • Research Institute of South Florida, Miami
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

U tijeku regrutacijaFaza 3
  • Optimus U Corporation, Miami
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

U tijeku regrutacijaFaza 3
  • New Horizon Research Center, Miami
  • Research Institute of South Florida, Miami
Od 18 do 99 godina · Oba spola · Ažurirano 27. kol 2026. · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

U tijeku regrutacijaFaza 3
  • Total Research Group LLC, Miami
  • Infinite Clinical Research, Miami
  • Future Life Clinical Trials, Miami
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

U tijeku regrutacijaFaza 3
  • ACCOMPLISH-1 Research Site, Miami
Od 18 do 79 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07654361

First in Human Study in Subjects With Obesity, But Otherwise Healthy

U tijeku regrutacijaFaza 1
  • Clinical Pharmacology of Miami, LLC, Miami
Od 18 do 65 godina · Oba spola · Ažurirano 9. tra 2026. · NCT06252220

Efficacy Trial of Healthy Together ("Juntos")

U tijeku regrutacijaZdravi dobrovoljci dobrodošli
  • University of Miami, Miami
Od 12 do 15 godina · Oba spola · Ažurirano 23. ožu 2026. · NCT06489262

With Love, Grandma ("Con Cariño, Abuelita") Pilot Study

U tijeku regrutacija
  • University of Miami, Miami
Od 21 godina i više · Žene · Ažurirano 25. velj 2026. · NCT05721976

Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Od 12 do 17 godina · Oba spola · Ažurirano 10. ruj 2025. · NCT06596265

Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Od 6 do 14 godina · Oba spola · Ažurirano 4. ruj 2025. · NCT06595251

Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Od 50 do 95 godina · Oba spola · Ažurirano 4. ruj 2025. · NCT06604650

RESET System Pivotal Trial (Rev F)

U tijeku regrutacija
  • University of Miami Hospital, Miami
Od 22 do 65 godina · Oba spola · Ažurirano 18. srp 2024. · NCT04101669

Studije za Debljina u drugim gradovima

Ostale studije u gradu Miami

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.